A Cannabis Company Sued By Its Former CEO Sets The Record Straight After False Claims Circulate

Bright Green Corporation BGXX is clapping back at statements made by its former CEO, John Fikany.

The Stockwells — specifically Bright Green director Lynn Stockwellreportedly approached Fikany to return as CEO.

Bright Green refuted this.

See Also: Bright Green Plans To Raise $500M Under EB-5 Capital Program

Fikany has filed a lawsuit against Bright Green, alleging fraud.

Bright Green insists it remains fully compliant with its Nasdaq listing and Securities and Exchange Commission (SEC) reporting before and after the listing. "There have been no allegations of securities fraud," the company stated.

The company "remains focused on the execution of its strategy, including processing the first applications following the announcement of the United States Citizenship and Immigration Services (“USCIS”) EB-5 program (...), and remains focused on concluding the DEA registration process, an important milestone for the Company."

The Benzinga Cannabis Capital Conference Is Back!

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A start, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Image Credits: Billion Photos and Yarygin by Shutterstock Edited By Benzinga

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksLegalMarketsBright Green CorporationCannabis LawsuitJerry CapussiJohn FikanyJohn StockwellLynn Stockwell
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.